Cargando…
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic neoplasm which results in clonal proliferation of abnormally differentiated hematopoietic cells. In this review, mechanisms contributing to myeloid leukemogenesis are summarized, highlighting aberrations of epigenetics, transcription fact...
Autores principales: | Bouligny, Ian M., Maher, Keri R., Grant, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693933/ https://www.ncbi.nlm.nih.gov/pubmed/35989139 http://dx.doi.org/10.1016/j.blre.2022.100996 |
Ejemplares similares
-
Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022
por: Bouligny, Ian M., et al.
Publicado: (2023) -
Augmenting Venetoclax Activity Through Signal Transduction in AML
por: Bouligny, Ian Michael, et al.
Publicado: (2023) -
Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023) -
Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023) -
RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019)